Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valbenazine for Tardive Dyskinesia in Adults with IDD
NCT06107829Phase 4Withdrawn
- Start
- Jan 2025
- Primary completion
- Jan 2027
- Modality
- Orthosteric Ligands, Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of valbenazine in tardive dyskinesia (TD). Planned start Jan 2025; status: withdrawn.
02
Drugs
valbenazine
03
Conditions
tardive dyskinesia (TD)
Beyond the preview
Go deeper on NCT06107829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06107829.